Global InformationHIV adult prevalence rate information
The human immunodeficiency virus (HIV), which causes AIDS, varies in prevalence from nation to nation. Listed here are the prevalence rates among adults in various countries, based on data from various sources, largely the CIA World Factbook.[1][2][3]
As of 2018, 38 million people are estimated infected with HIV globally.[4]
The HIV pandemic is most severe in Southern Africa. Over 10% of all people infected with HIV/AIDS reside within the region. Adult HIV prevalence exceeds 15% in Eswatini, Botswana, and Lesotho, while an additional six countries report adult HIV prevalence of at least 10%.
In absolute numbers, South Africa (7.5 million), followed by Mozambique (2.2 million), India (2.1 million) and Nigeria (1.8 million) had the highest HIV/AIDS number of cases by the end of 2022.[2][5] While South Africa's large population of HIV-positive people is attributable to its high disease prevalence (17.3%, one of the highest in the world), Nigeria's is lower at 1.3%, with India's prevalence rate at 0.2%.[1] However, countries such as Nigeria with high HIV rates above 1% are classified as having Generalized HIV Epidemics (GHEs) by UNAIDS, while India's prevalence is well below this threshold, with a prevalence lower than the US's and about the same as Spain.[6]
- ^ a b "HIV/AIDS – adult prevalence rate – The World Factbook". www.cia.gov. Archived from the original on 2022-04-25. Retrieved 2021-01-17.
- ^ a b "HIV/AIDS – people living with HIV/AIDS – The World Factbook". www.cia.gov. Archived from the original on 2021-02-04. Retrieved 2021-01-17.
- ^ "HIV/AIDS – deaths – The World Factbook". www.cia.gov. Archived from the original on 2021-01-24. Retrieved 2021-01-17.
- ^ "Global HIV & AIDS statistics — 2020 fact sheet". www.unaids.org. Retrieved 2021-01-17.
- ^ "The Hindu – India has 3rd-highest number of HIV-infected people: UN". The Hindu. 2014-07-17.
- ^ Kenyon, C.; Buyze, J. (2014). "Should the threshold for a generalised HIV epidemic be 1% or 5%?". International Journal of STD & AIDS. 25 (12): 898–900. doi:10.1177/0956462414526575. PMID 25278511. S2CID 10387855.